Intelligence Β· Patent portfolio
Rani Therapeutics Holdings Patents
Full USPTO pharma patent portfolio for Rani Therapeutics Holdings β grant dates, expiration, and drug cross-links.
- Patents
- 148
- Expiring β€24m
- 1
Quick answer
Rani Therapeutics Holdings has 148 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months β use filters for patent-cliff planning.
-
US 12357555
Self-emulsifying composition, intended for administration onto the skin, containing biosurfactant, cosurfactant and oil phase
granted -
US 12268831
Swallowable drug delivery device and methods of drug delivery
granted -
US 12263325
Device, system and methods for the oral delivery of therapeutic compounds
granted -
US 12214019
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
granted -
US 12201721
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 12168692
Antibodies targeting CCR2
granted -
US 12128133
Ingestible device with expandable enclosure
granted -
US 12077551
Zinc complex, preparation thereof and use thereof for trerapy of human and animal diseases
granted -
US 12018090
PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11844867
Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11826464
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 11814427
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11813314
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11806504
Device, system and methods for the oral delivery of therapeutic compounds
granted -
US 11771879
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11718665
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
granted -
US 11684761
Preparation comprising exanatide for delivery into a lumen of the intestinal tract
granted -
US 11654182
Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11638690
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11555068
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11548940
Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11464737
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 11419812
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11376405
Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11352639
Gene therapy based on vector VTVAF17
granted -
US 11338118
Swallowable drug delivery device and methods of drug delivery
granted -
US 11304895
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11304993
Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
granted -
US 11291709
Pharmaceutical compositions and methods for fabrication of solid masses comprising TNF-inhibiting antibodies
granted -
US 11253686
Swallowable drug delivery device and methods of drug delivery
granted -
US 11229684
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 11026998
Shaped mass composition comprising exenatide
granted -
US 10987499
Swallowable drug delivery device and method of delivery
granted -
US 10980749
Therapeutic preparation comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10967050
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10953077
Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10926073
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10888517
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10874840
Preparation comprising exanatide for delivery into a lumen of the intestinal tract
granted -
US 10864254
Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10849878
Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon
granted -
US 10752681
Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10675482
Device and method for use of photodynamic therapy
granted -
US 10639272
Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 10632251
Device, system and methods for the oral delivery of therapeutic compounds
granted -
US 10603475
Swallowable drug delivery device and methods of drug delivery
granted -
US 10603275
Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device
granted -
US 10596359
Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
granted
Frequently asked questions
How many patents does Rani Therapeutics Holdings have?
148 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Rani Therapeutics Holdings patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory